Adage Capital Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Adage Capital Partners’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-190,000	Closed	-$12M	–	836
2020 Q2	$12M	Hold	190,000	–	–	0.03%	500
2020 Q1	$7.98M	Hold	190,000	–	–	0.02%	504
2019 Q4	$8.63M	Hold	190,000	–	–	0.02%	558
2019 Q3	$8.7M	Hold	190,000	–	–	0.02%	548
2019 Q2	$11.1M	Hold	190,000	–	–	0.03%	511
2019 Q1	$8.52M	Hold	190,000	–	–	0.02%	551
2018 Q4	$7.4M	Buy	190,000 +15,000	+9%	+$589K	0.02%	554
2018 Q3	$8.05M	Sell	175,000 -25,000	-13%	-$1.01M	0.02%	576
2018 Q2	$8.72M	Buy	200,000 +50,000	+33%	+$2.15M	0.02%	584
2018 Q1	$5.92M	Buy	+150,000	New	+$5.83M	0.01%	628

Other funds holding ARNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Adage Capital Partners's ARNA Position: Q3 2020 in Review

Adage Capital Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2020, closing a stake of 190,000 shares — an estimated $12M sold.

Adage Capital Partners first reported a position in ARNA in Q1 2018 and held it in 10 quarters. The position peaked at $12M in Q2 2020. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

Adage Capital Partners reported no remaining Arena Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
Adage Capital Partners sold 190,000 Arena Pharmaceuticals Inc shares in Q3 2020, an estimated $12M.
Adage Capital Partners first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 10 quarters.
Adage Capital Partners's Arena Pharmaceuticals Inc position peaked at $12M in Q2 2020.
253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.